Management

The Helmholtz Centre for Infection Research (HZI) is organised in the form of a GmbH (equals “Ltd.”). Shareholders are the Federal Republic of Germany (90 percent) and the federal states Lower-Saxony (eight percent), Saarland (one percent) and Free State of Bavaria (one percent).

The shareholders' meeting, as the supreme management body of the HZI, meets at least once a year, takes the most important directional decisions, appoints the two managing directors and decides on their discharge. Representatives of the shareholders - together with experts from universities, clinics, industry, other research centres and the HZI itself - form the supervisory board. The HZI Supervisory Board meets twice a year, supervises the legality, expediency and economic efficiency of the management and decides on important research policy and financial matters of the company. The Scientific Committee provides the Supervisory Board with expert advice. The Centre's middle management consists of the heads of the scientific departments, the administrative units and the staff units.

Supervisory Board

The Supervisory Board oversees the legality, expedience and economy of the management. It decides on general research goals, the principal research policy and financial affairs of the centre. It consists of a maximum of 15 members.

Members of the Supervisory Board

PrintSend per emailShare